Approval · Notice of Compliance 13304 · 2012
NORLEVO: Notice of Compliance 13304
Issued May 24, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13304
- Date
- May 24, 2012
- Company
- Laboratoire Hra PharmaChâtillon, --, France
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes in spcifications, new drug product manufacturing site, change in shelf-life spcifications, changes in the embossing for the finished product
- Therapeutic class
- Emergeny Contraception
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORLEVO | Not yet assigned | — |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB